Literature DB >> 1168218

Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.

P J Baker, T F Lint, B C McLeod, C L Behrends, H Gewurz.   

Abstract

Multiple polyanions and polycations were tested for their ability to influence formation of EC567 from C56, C7, and sheep erythrocytes. Six of 11 polyanions tested, including polyanethol sulfonate, heparin, and dextran sulfate, inhibited this reaction. By contrast, polycations (five or seven tested), including polybrene, protamine, and polyornithine, potentiated formation of EC567. The inhibition was similar to that previously described for anionic serum factors termed C567-INH, while the potentiation seemed to involve neutralization of serum C567-INH. Thus, this step of the complement attack mechanisms seems amenable to modulation by certain polyelectrolytes, and may thereby be susceptible to pharmacologic manipulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168218

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility.

Authors:  You-Xiong Wang; John L Robertson; William B Spillman; Richard O Claus
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Regulation of C5 convertase activity by properdin, factors B and H.

Authors:  J M Weiler
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Eosinophil granule cationic proteins regulate the classical pathway of complement.

Authors:  J M Weiler; R E Edens; C S Bell; G J Gleich
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

4.  Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.

Authors:  P J Baker; T F Lint; J Siegel; M W Kies; H Gewurz
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

5.  Inhibition of the alternative pathway of complement by glomerular chondroitin sulphate proteoglycan.

Authors:  R J Quigg
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

6.  Modulation of the formation of the human amplification C3 convertase of complement by polycations.

Authors:  F Maillet; M D Kazatchkine
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

Review 7.  Discrimination between host and pathogens by the complement system.

Authors:  Michael K Pangburn; Viviana P Ferreira; Claudio Cortes
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

8.  Effects of zinc chloride on guinea pig complement component activity in vitro: concentration-dependent inhibition and enhancement.

Authors:  D W Montgomery; M Chvapil; C F Zukoski
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 9.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

10.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.